Cogent Biosciences, Inc. (COGT)
USD 4.18
(3.86%)
USD 4.18
(3.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 7.87 Million | 22.49 Million | 9.73 Million |
| Cost of Revenue | 3.58 Million | 5.87 Million | 147 Thousand | 25.73 Thousand | 43.7 Thousand | - |
| Gross Profit | -3.58 Million | -5.87 Million | -147 Thousand | 7.84 Million | 22.45 Million | 9.73 Million |
| Operating Expenses | 208.13 Million | 147.83 Million | 75.55 Million | 90.07 Million | 54.67 Million | 45.73 Million |
| Selling, General and Administrative Expenses | 34.37 Million | 26.21 Million | 19.63 Million | 17.42 Million | 10.96 Million | 7.45 Million |
| Research and Development Expenses | 173.75 Million | 121.62 Million | 55.91 Million | 72.64 Million | 43.7 Million | 38.28 Million |
| Other Expenses | - | 3.6 Million | 2.81 Million | -246 Thousand | 78 Thousand | 320 Thousand |
| Cost and Expenses | 208.13 Million | 147.83 Million | 75.55 Million | 90.07 Million | 54.67 Million | 45.73 Million |
| Operating Income | -208.13 Million | -147.83 Million | -75.55 Million | -82.19 Million | -32.17 Million | -36 Million |
| Interest Expense | - | 3.98 Million | - | - | - | - |
| Income Tax Expense | - | -7.59 Million | -467 Thousand | -8.35 Million | -1.56 Million | 1.47 Million |
| Earnings before Tax | -192.41 Million | -140.24 Million | -72.27 Million | -74.8 Million | -31.83 Million | -34.53 Million |
| Net Income | -192.41 Million | -132.64 Million | -71.8 Million | -66.45 Million | -30.27 Million | -34.53 Million |
| Earnings Per Share Basic | -2.42 | -2.26 | -1.85 | -6.00 | -3.97 | -5.55 |
| Earnings Per Share Diluted | -2.42 | -2.26 | -1.85 | -6.00 | -3.97 | -5.55 |
| Weighted Average Shares Outstanding | 79.65 Million | 58.73 Million | 38.73 Million | 11.08 Million | 7.62 Million | 6.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.65 Million | 58.73 Million | 38.73 Million | 11.08 Million | 7.62 Million | 6.22 Million |
| Gross Margin | - | - | - | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | - | - | -11.40 | -1.43 | -3.56 |
| Profit Margin | - | - | - | -8.44 | -1.35 | -3.55 |
| EBITDA | -205.86 Million | -134.36 Million | -75.4 Million | -34.56 Million | -30.88 Million | -34.68 Million |
| Earnings Before Tax Margin | - | - | - | -10.44 | -1.43 | -3.70 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 5.58 Million | - | - |
| Cost of Revenue | 1.08 Million | 1.06 Million | 3.58 Million | 794 Thousand | 855 Thousand | 1.21 Million |
| Gross Profit | -1.08 Million | -1.06 Million | -3.58 Million | 4.79 Million | -855 Thousand | -1.21 Million |
| Operating Expenses | 63.3 Million | 62.4 Million | 204.54 Million | 58.22 Million | 59.58 Million | 47.08 Million |
| Selling, General and Administrative Expenses | 10.09 Million | 9.69 Million | - | 9.5 Million | 9.45 Million | 8.21 Million |
| Research and Development Expenses | 53.21 Million | 52.7 Million | - | 48.71 Million | 50.12 Million | 38.87 Million |
| Other Expenses | 44 Thousand | -1000.00 | - | -7000.00 | - | 268 Thousand |
| Cost and Expenses | 64.38 Million | 62.4 Million | 208.13 Million | 58.22 Million | 59.58 Million | 47.08 Million |
| Operating Income | -64.38 Million | -62.4 Million | -208.13 Million | -58.22 Million | -59.58 Million | -47.08 Million |
| Interest Expense | - | - | - | 4.65 Million | - | - |
| Income Tax Expense | - | -4.05 Million | - | -3.87 Million | -855 Thousand | -3.95 Million |
| Earnings before Tax | -58.95 Million | -58.34 Million | -192.41 Million | -54.36 Million | -55.38 Million | -44.07 Million |
| Net Income | -58.95 Million | -58.34 Million | -192.41 Million | -54.36 Million | -55.38 Million | -44.07 Million |
| Earnings Per Share Basic | -0.59 | -0.62 | - | -0.63 | -0.64 | -0.59 |
| Earnings Per Share Diluted | -0.59 | -0.62 | - | -0.63 | -0.64 | -0.59 |
| Weighted Average Shares Outstanding | 99.24 Million | 94.8 Million | 79.65 Million | 86.73 Million | 86.16 Million | 74.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 99.24 Million | 94.8 Million | 79.65 Million | 86.73 Million | 86.16 Million | 74.75 Million |
| Gross Margin | - | - | - | 0.86 | - | - |
| EBIT Margin | - | - | - | -10.28 | - | - |
| Profit Margin | - | - | - | -9.73 | - | - |
| EBITDA | -63.3 Million | -61.33 Million | - | -57.43 Million | -59.58 Million | -47.08 Million |
| Earnings Before Tax Margin | - | - | - | -10.42 | - | - |
9914
TGEN
9926
BNPQY
0JZ8
003495